Harrow (HROW) Change in Inventory (2014 - 2026)
Harrow's (HROW) quarterly Change in Inventory came in at $3.0 million in Q1 2026, up 21135.71% year-on-year from N/an in Q1 2025, and up 331.49% quarter-over-quarter from $689000.0 in Q4 2025.
Harrow (HROW) Change in Inventory (2014 - 2026) Analysis & Trends
Harrow's Change in Inventory history runs 13 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- On a quarterly basis, Change in Inventory rose 21135.71% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $5.8 million, a 6248.94% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 1809.7% from the prior year.
- Change in Inventory advanced to $3.0 million in Q1 2026 per HROW's latest filing, from $689000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $3.0 million in Q1 2026 and bottomed at -$1.4 million in Q2 2024.
- The 5-year median for Change in Inventory is $689000.0 (2025), against an average of $722294.1.
- Across the five-year window, Change in Inventory plunged 173.1% in 2023 and surged 21135.71% in 2026, its largest moves.
- Year by year, Change in Inventory stood at $1.3 million in 2022, then soared by 54.45% to $1.9 million in 2023, then sank by 71.9% to $546000.0 in 2024, then rose by 26.19% to $689000.0 in 2025, then soared by 331.49% to $3.0 million in 2026.
- Per Business Quant, the three latest HROW Change in Inventory figures stand at $3.0 million (Q1 2026), $689000.0 (Q4 2025), and $1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | 2.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.97 Mn |
| Mar 31, 2026 | 2.97 Mn |
| Dec 31, 2025 | 689,000.00 |
| Dec 31, 2025 | 689,000.00 |
| Sep 30, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 836,000.00 |
| Jun 30, 2025 | 836,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 546,000.00 |
| Dec 31, 2024 | 546,000.00 |
| Sep 30, 2024 | 731,000.00 |
| Sep 30, 2024 | 731,000.00 |
| Jun 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -57,000.00 |
| Mar 31, 2024 | -57,000.00 |
| Dec 31, 2023 | 1.94 Mn |
| Dec 31, 2023 | 1.94 Mn |